Stock AnalizLabcorp (LH) earnings for the quarter ended September 2026: EPS beats estimates
Labcorp reported results for the quarter ended September 2026 on October 28, 2026. Adjusted earnings per share came in at $4.78 against the analysts’ average forecast of $4.64, a beat of 2.9%.
Revenue for the quarter was $3.81 billion, up 6.9% from $3.56 billion in the same quarter a year earlier.
The market’s verdict: the stock rose 8.8% on the first trading day after the report.
The last four quarters
Labcorp has beaten the analysts’ EPS forecast in 4 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $4.78 | $4.64 | +2.9% | +7% | +8.8% |
| Jun 2026 | $4.99 | $4.77 | +4.7% | +6% | +0.7% |
| Mar 2026 | $4.25 | $4.12 | +3.3% | +6% | −0.5% |
| Sep 2025 | $4.18 | $4.14 | +1.0% | +9% | −10.0% |
What comes next
Analysts expect EPS of $4.51 for the next quarter on average and $18.49 for the fiscal year ending December 31, 2026.
The average analyst price target is $390.06, 5% above the current price of $370.48.
Valuation and score
Labcorp scores 2.0 out of 5 overall on Stock Analiz (average), trades at a trailing P/E of about 30.4, and its intrinsic value under moderate assumptions is about 14% below the current market value. Full Labcorp analysis with 10 years of financials
Frequently asked questions
What was Labcorp’s EPS for the quarter ended September 2026?
$4.78 adjusted per share, against an analyst consensus of $4.64.
How much revenue did Labcorp report?
$3.81 billion, up 6.9% year over year.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.